US
European biotechs outperform US for investment return, report claims
November 29, 2017Medical Communications, Sales and Marketing EU, Europe, US, investment, pharma
A new report from RSA Group has revealed that European biotech companies are “significantly outperforming” their US counterparts in terms …
Children are still prescribed codeine despite FDA warnings, study finds
November 20, 2017Medical Communications, Research and Development, Sales and Marketing US, codeine, opioid crisis, opioids, pharma
A new study from the American Academy of Pediatrics has found that, despite warnings from the FDA, doctors are still …
Indivior’s opioid addiction treatment recommended by FDA advisory panel
November 1, 2017Research and Development, Sales and Marketing FDA, RGP-6000, Trump, US, indivior, opioid crisis, opioids
Another step has been made in the fight back against the ongoing opioid crisis in the US as it emerges …
Novartis sheds generics plant and 450 jobs amid pricing pressure
October 18, 2017Manufacturing and Production, Research and Development Novartis, US, closure, generics, manufacturing, pharma
Novartis has announced its intention to shut down its US generics manufacturing plant in Broomfield, Colorado, a move that will …
Lupin scoops up women’s health specialist Symbiomix for $150 million
October 11, 2017Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma
The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …
Novo Nordisk settles lawsuit over illegal marketing practices for $58.7 million
September 6, 2017Research and Development, Sales and Marketing FDA, Novo Nordisk, US, US Justice Department, Victoza, diabetes, pharma, pharmaceutical
Novo Nordisk has resolved a probe by the US Justice Department which accused the Danish drugmaker of illegal marketing activities …
Sanofi backs out of controversial Zika vaccine project
September 4, 2017Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical
Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
One in twelve US doctors accepted opioid-related payments from pharma, finds study
August 10, 2017Medical Communications, Sales and Marketing US, bribe, drugs, life sciences, medicine, opioids, pharma, pharmaceutical
In the first large-scale study of its kind, a team of researchers at Boston Medical Center’s Grayken Center for Addiction …
FDA gives approval for Gilead’s hepatitis C therapy
July 19, 2017Research and Development, Sales and Marketing FDA, Gilead, US, Vosevi, biotech, drugs, healthcare, pharma, pharmaceutical
The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …
New director of CDC courts controversy from all angles
July 10, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDC, Trump, US
It seems that an appointment in Trump’s administration cannot avoid being a topic of some controversy. That’s the case with …
Sanofi to pay $20m fine for overcharging US veterans
April 4, 2017Manufacturing and Production, Sales and Marketing Sanofi, Sanofi Pasteur, US
Sanofi Pasteur, the French firm’s vaccines unit, has agreed to pay a $19.8 million settlement over claims it overcharged the …
EU-US reach landmark deal on mutual recognition of manufacturing inspection
March 3, 2017Medical Communications EMA, EU, FDA, US
The European Union and the US has announced that an agreement has been made to mutually recognise inspection of drug …
Obama seals $6.3 billion 21st Century Cures Act
December 14, 2016Medical Communications, Research and Development Biden, Obama, US, congress
President Barack Obama put pen to paper on the 21st Century Cures Act on 13 December, which commits to investing …
Pfizer sues Texas agency over leak of drug prices
November 21, 2016Medical Communications, Sales and Marketing Drug pricing, Pfizer, US, texas
Pfizer has sued Texas’ Health and Human Services Commission, after it claimed the agency violated state and federal law by …
Myelofibrosis market to increase to be worth over $1 billion by 2025
November 16, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, US, myelofibrosis
The myelofibrosis market is expected to grow from $545.2 million in 2015 to $1.02 billion by 2025, almost doubling in …
Latest content
FibroFind appoints Lee Borthwick as CEO
